Purpose
The current study presents a novel treatment strategy involving short-segment posterior fixation and transpedicular bone grafting combined with recombinant human bone morphogenetic protein-2 (rhBMP-2). The aimed is to investigate the clinical efficacy in treating thoracolumbar burst fracture (TLBF).
Methods
Patients with acute TLBF requiring surgical treatment were conducted. Enrolled patients were randomly assigned to either the intervention or control groups. All patients underwent short-segment posterior fixation treatment, with the intervention group receiving additional transpedicular bone grafting and rhBMP-2 into the fractured vertebral body using vertebroplasty instrumentation. In contrast, the control group did not undergo any bone implantation procedures. Preoperative and postoperative imaging indices, including Sagittal Cobb Angle (SCA) and Anterior Vertebral Height Ratio (A VHR), as well as fracture healing rate, were assessed. Treatment indices, such as the visual analog scale (VAS), were also measured. Furthermore, general information was compared between the two groups.
Results
There were 24 patients enrolled in the intervention group, and 36 patients in the control group. Demographic data showed no significant differences between groups (P > 0.05). One year after the operation, the SCA was significantly lower in both groups compared to the preoperative period. However, the intervention group exhibited less loss in SCA compared to the control group at the 1-year follow-up (P < 0.05). There was no significant difference in the anterior A VHR between the two groups at 7 days, 3 months, and 1 year after operation (P > 0.05). Regarding the fracture healing rate, the postoperative Lane-Sandhu scores of both groups increased significantly. At 3 months after surgery, the observation group showed a significantly higher score than the control group (P < 0.05).
Conclusion
This RCT demonstrated that the short-segment posterior fixation and transpedicular vertebral bone graft combined with rhBMP-2 can effectively reduce the SCA and accelerate fracture healing.